“It is always an honor to be recognized by Castle Connolly. My goal is to provide each patient with a truly individualized treatment plan to achieve their personal cosmetic surgery goals,” says Dr. B Aviva Preminger.
More about Dr. B. Aviva Preminger:
Dr. Preminger is an Ivy League-educated, board-certified plastic surgeon. She trained at some of the country’s finest institutions, graduating magna cum laude from Harvard University. She later went on to receive her medical doctorate from Cornell University Medical College and completed her surgical training at the prestigious New York Presbyterian Hospital-Cornell/Columbia, training under some of the most renowned cosmetic and reconstructive surgeons in New York City. For more information on the services offered by Dr. Preminger, please visit http://www.premingermd.com, or contact her office, located at 969 Park Ave., Suite 1E in New York City, directly at (212)-706-1900.
Excellence in comprehensive dentistry is what they provide at Neville Dental Studio. The clinic welcomes patients of all ages to its modern dental facilities with locations in the Bowling Green, KY, area.
BOWLING GREEN, Ky., Dec. 21, 2023 /PRNewswire-PRWeb/ — The sudden closure of SmileDirectClub, a prominent player in the telehealth orthodontics space, serves as a crucial reminder that when it comes to orthodontic treatments, patients need a reliable and individualized approach. In light of this event, Neville Dental Studio emphasizes the importance of choosing a trusted, experienced and patient-centered dental care provider for orthodontic treatments. At Neville Dental Studio, they offer Invisalign, a leading-edge orthodontic solution, backed by the dental team’s 40+ years of experience and a commitment to personalized, non-corporate patient care. Invisalign, a revolutionary clear aligner system, has transformed orthodontic treatment by offering a discreet, comfortable and effective way to straighten teeth. Neville Dental Studio’s deep understanding of orthodontic needs ensures that Invisalign treatment is tailored to each patient’s unique dental profile, guaranteeing the best possible outcomes. At Neville Dental Studio, Invisalign treatment begins with a thorough dental evaluation. Regular, in-person appointments allow the team to closely monitor progress, make timely adjustments and provide immediate responses to any concerns. This hands-on approach ensures that patients receive the highest level of care and attention, and Neville Dental Studio prioritizes stability and continuity throughout the Invisalign journey, from the initial consultation to the final results. Neville Dental Studio is also offering a special pricing of $2,995 for Invisalign cases that sign up between now and January 31st, 2024.
Whether clients are athletes looking to boost performance or individuals seeking relief from daily discomfort, The Stretch Masters caters to all needs. Their myofascial release therapy is particularly effective for those suffering from chronic pain or movement restrictions, offering transformative results.
The Stretch Masters’ commitment to excellence is further strengthened by their partnership with the esteemed Allied Pain & Spine Institute. This collaboration allows them to offer a truly comprehensive approach to health and well-being.
“Our team provides the necessary support and guidance for clients to take charge of their health and lead healthier lives. We are not just about stretching muscles; we’re about unlocking the body’s full potential through a unique blend of techniques and expert insights,” says a representative from The Stretch Masters.
About The Stretch Masters:
At The Stretch Masters, empowering clients with knowledge and tools for sustained wellness is paramount. A first-time client can expect a thorough assessment, personalized techniques, and a focus on relaxation to enhance flexibility and mobility. Located at 1604 Blossom Hill Rd, Ste. 8 in San Jose, California, The Stretch Masters invites you to experience their unique approach. For more information, visit http://www.mystretchmasters.com, call (408) 521-0080, or email [email protected]
Annual Awards Programs: The Advisory Board actively shapes coveted annual awards programs, defining categories, reviewing thousands of nominations, and selecting winners for prestigious accolades such as the CPO Awards, the Product Awards, and the PM Awards.
Product Talk Podcast: Members lead the award-winning Product Talk podcast, reaching millions of listeners globally. They curate and host discussions with exceptional product leaders from top organizations worldwide.
Startup Ecosystem Connection: The Advisory Board facilitates connections between startup founders and Mighty Capital, a leading venture firm in the Bay Area dedicated to early-stage companies.
The diverse composition of the Advisory Board includes accomplished individuals such as Bill Loewenthal of ChargePoint, Jay Schneider of Royal Caribbean, and Jennifer Rochlis of NASA, among others. A comprehensive list of members is available below.
“We are honored to recognize and celebrate these remarkable Advisory Board members who bring unparalleled expertise and innovation to our organization,” said Products That Count Founder and Board Chair SC Moatti. “Their contributions significantly impact the product management field, and we look forward to the continued success and growth of our network.”
For further information about the Advisory Board and its members, please visit productsthatcount.com. Join us in raising a glass to these outstanding individuals who truly represent the pinnacle of excellence in product management.
Products that Count is a 501(c)(3) nonprofit that helps everyone build great products. It celebrates product excellence through coveted Awards that inspire 500,000+ product managers and honor great products and the professionals responsible for their success. It accelerates the career and rise to the C-suite of >30% of all Product Managers globally by providing exceptional programming – including award-winning podcasts and popular newsletters – for free. It acts as a trusted advisor to all CPOs at Fortune 1000, and publishes key insights from innovative companies, like Capgemini, SoFi, and Amplitude, that turn product success into business success. Learn more at ProductsThatCount.com.
Patients with POTS can use their Apple Watch to perform recumbent exercise at home, using a new version of the Empirical Health iPhone app which adds support for iOS 17’s WorkoutKit features.
NEW YORK, Dec. 21, 2023 /PRNewswire-PRWeb/ — Empirical Health is excited to announce the launch of an innovative exercise program specifically designed for patients with Postural Orthostatic Tachycardia Syndrome (POTS).
Inspired by the renowned CHOP/Levine protocol, this new program integrates with the latest technology offered by iOS 17 and watchOS 10. Utilizing the new WorkoutKit API, the program preloads a set of carefully tailored recumbent workouts directly onto the patient’s Apple Watch. These exercises are designed to gradually build the patient’s tolerance for exercise, a critical aspect of managing POTS symptoms.
Key Features of the Program:
Tailored Exercise Regimen: Developed in consultation with medical experts, the program includes a variety of recumbent workouts that gradually increase in intensity. This approach is essential for safely improving exercise tolerance in POTS patients.
Technology Integration: Leveraging the capabilities of the Apple Watch and the latest WorkoutKit API, the program provides an accessible and user-friendly platform for POTS patients to manage their exercise routine.
Data-Driven Insights: The Apple Watch’s advanced sensors allow for continuous monitoring of vital signs, offering valuable insights into the patient’s response to the exercise regimen and enabling personalized adjustments to the program.
“People with POTS can sometimes find it challenging to travel to a physical therapist clinic,” said Dr. Raquel Rodriguez, Chief Medical Officer of Empirical Health, “Luckily, at-home exercise programs have shown benefit in several research studies. In one of these studies 77% of participants no longer met the heart rate criteria for POTS after 6 months of the program.”
A Commitment to Better Health:
Empirical Health is committed to improving the lives of those living with POTS. “Our goal is to empower POTS patients through technology and innovation,” says Brandon Ballinger, CEO of Empirical Health. “This program is a testament to that commitment, offering a new avenue for managing symptoms and improving quality of life.”
Availability:
The Empirical Health exercise program for POTS patients is available now. For more information on how to enroll and start managing POTS symptoms more effectively, visit https://empirical.health/.
About Empirical Health
Empirical Health is a health technology company building proactive primary care for those with chronic illness. Empirical Health was founded by a doctor and an engineer, is backed by Y Combinator, and is used by more than 10,000 people.
“We have always been dedicated to ensuring the safety, privacy, and dignity of all senior residents and patients,” stated Bob Nahorski, Chief Sales Officer at RF Technologies. “We are excited about our partnership with Ban-Koe, which will provide family members and healthcare staff with greater assurance that their loved ones and patients are being cared for properly and kept safe. As we strive to expand and strengthen our dominance in the long-term care market, partnering with Ban-Koe was an obvious choice. We are delighted to welcome their superior level of services in the Midwest to our customers.”
RF Technologies Code Alert® system provides healthcare staff with real-time location tracking, fall detection, and patient identification alerts, allowing staff to respond quickly to incidents and provide necessary patient care.
The system also gives residents the discreet option of wearing transmitters reducing wandering while helping staff stay informed and aware of residents’ whereabouts.
“We’re thrilled to partner with RF Technologies and offer this innovative solution to our customers,” said Dan Daley, VP Sales of Ban-Koe Companies. “The integration of the Code Alert® Quick Response Nurse Call with Wander Management system into our existing security and life safety solutions is a perfect fit. This expansion enhances our suite of security solutions, prioritizing safety and secure living environments. Previously, we provided comprehensive segments of the solution for healthcare, and now, with the RF Technologies suite of solutions for long-term care, we can position ourselves completely.”
About RF Technologies RFT is a turn-key manufacturer and provider of life safety solutions for the senior living, healthcare, education, and hospitality markets. With 11,000+ installations since their founding in 1987, RFT is a collaborative partner in designing custom-configured solutions that meet each customer’s needs and reduce their liabilities. The RFT family of solutions includes CODE ALERT® nurse call, fall detection, and wander management, SAFE PLACE® patient, staff, and asset protection, HELP ALERT® staff duress, and SENSATEC® fall management products.
About Ban-Koe Companies Ban-Koe is a leading provider of comprehensive solutions for workplace security and managing the workforce. With a wide range of integrated hardware, software, and services, Ban-Koe delivers cutting-edge technology to help businesses improve their operations and safeguard their premises. Since 1981, the company has designed and partnered with top innovators to provide solutions that help streamline workforce management processes, enhance employee productivity, and optimize operational efficiency while maintaining a safe and secure working environment.
“We anticipate an immediate, positive social impact with the launch of our new Phlebotomy Technician program with flexible learning modules at a reasonable cost” said Shamsah Noorani, CEO of Health Tech Academy. “This program will quickly increase students’ return on education. In sixteen weeks, people can study, obtain the certification, and land a meaningful career serving patients in a phlebotomy technician capacity. The bootcamp features a dynamic curriculum designed to provide students with the skills today’s employers need, alongside opportunities for peer networking, and hands-on experience.”
Direct, day-one access to expert healthcare coaches is one of several headline elements that HTA’s newest bootcamp offers. Students can practice newfound skills in record-keeping, patient care, and data analysis in a risk-free setting featuring feedback from leaders in the phlebotomy space. Students navigate self-paced units at their own preferred pace, at less than one-third the cost of a traditional college degree program. Exam fees, course materials, and certification costs are all included in a single fee that prepares learners for healthcare employment in 3-4 months.
“Our Phlebotomy Tech bootcamp streamlines education for a new healthcare career path” said Health Tech Academy’s Product and Programs Manager, Danish Khan. “Each feature of our Phlebotomy Technician bootcamp, specifically our online learning modules and our “study now, pay later” financing options with our partners like Edly and Salli Mae, was designed and implemented to accelerate the rate of student education and equip the workforce with much-needed phlebotomy skills.”
This bootcamp is the latest in Health Tech Academy’s line of healthcare career certification programs, including online programs for aspiring dental assistants, medical assistants, patient care technicians, and surgical technologists, to mention a few. They remain committed to offering a faster path to employment in the healthcare sector, behind curriculums engineered to accommodate already-busy lives. Without a two-year campus commitment or six figures of debt, Health Tech Academy connects the next generation of phlebotomy technicians with well-paying medical positions on your timeline.
Current JAK inhibitors work well against inflammation in diseases like eczema, but the study suggests a need for a nuanced approach in modulating JAK activity for conditions like asthma. The potential shift toward enhancing, rather than blocking, JAK activity in lung neurons could be a transformative strategy, distinct from traditional JAK inhibitors that mainly target immune cells, say the investigators.
As part of the work, a mouse made with a patient-specific mutation in the gene for JAK1 revealed how this mutant protein causes disease and how it could potentially be harnessed for broader therapeutic use. The study showed that activated JAK1 signaling has tissue-specific effects, including an unexpected immunoregulatory role in lung sensory neurons, where it suppresses lung inflammation.
“This may explain why JAK1-selective inhibitors, while highly successful in atopic dermatitis, have not advanced for asthma treatment and implies that JAK1 signaling has varying or even opposing effects in different cell types and tissues,” says lead study author Brian Kim, MD, MTR, FAAD, the Sol and Clara Kest Professor of Dermatology, Vice Chair for Research, and Director of the Mark Lebwohl Center for Neuroinflammation and Sensation at Icahn Mount Sinai.
The study involved a type of JAK1 gain-of-function (GOF) mutation, first reported by study co-author Stuart Turvey, MBBS, DPHIL, FRCPC in 2017, from patients with an immune dysregulatory and hypereosinophilic syndrome characterized by severe eczema and asthma. A JAK1 GOF mutation is a change in the gene that encodes the JAK1 protein, making it more active than normal. This increased activity can lead to overactive immune responses and may cause health problems like autoimmune diseases or cancer.
“As a pediatrician, I started this work with a commitment to finding a diagnosis and treatment for a family where three members had severe eczema, asthma, and other allergic manifestations. It turned out that they were the first people in the world recognized to have a genetic change causing gain of function of JAK1,” says Dr. Turvey, Professor, Division of Immunology, Department of Pediatrics, Faculty of Medicine, and Canada Research Chair in Pediatric Precision Health, BC Children’s Hospital and The University of British Columbia, Vancouver, Canada. “Today’s publication, led by Dr. Kim and his team at Mount Sinai, is a powerful example of globally collaborative translational research where they started with this single family and have now generated fundamental insights into the interactions between the human immune system and the nervous system. This is precision medicine in practice.”
Previous research by Dr. Kim and his team revealed that JAK1 signaling, typically responsible for regulating immune cells’ inflammatory response, is also present in neurons and controls the sensation of itch.
In their new study, Drs. Kim and Turvey created mice with the same genetic mutation as the patients to better understand why JAK1 inhibitors work for some allergy and inflammatory conditions.
In the lung neurons of the mice, the JAK1 mutant protein reduced inflammation caused by exposure to mold by producing substances that suppress inflammation. However, the mice still showed the same skin condition as the original patients, indicating that JAK1 signaling has different effects in different cells and even within the same cell type in different parts of the body.
“Better understanding of JAK signaling in different parts of the body not only helps us discover new things about biology but also gives us a glimpse into how JAK medicines might be used in the evolving landscape of innovative treatments,” says Dr. Kim.
Next, the researchers plan to examine how additional genes along the JAK pathway may also inform tissue-specific patterns of disease. “For example, another protein called STAT6 is further downstream of the JAK1 pathway. Dr. Turvey has found patients with mutations in these genes who also develop similar allergic conditions. However, whether these specific mutations can inform therapeutic strategies for specific diseases remains a very exciting field of inquiry,” says Dr. Kim.
The paper is titled “Sensory Neurons Promote Immune Homeostasis in the Lung.” Please see DOI: 10.1016/j.cell.2023.11.027 to view details on the remaining authors, funding, and competing interests.
About the Icahn School of Medicine at Mount Sinai
The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight- member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.
Ranked 14th nationwide in National Institutes of Health (NIH) funding and among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 3,000 full-time scientists, educators, and clinicians work within and across 44 academic departments and 36 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, as well as gastrointestinal and liver diseases.
Icahn Mount Sinai offers highly competitive MD, PhD, and Master’s degree programs, with current enrollment of approximately 1,300 students. It has the largest graduate medical education program in the country, with more than 2,000 clinical residents and fellows training throughout the Health System. In addition, more than 550 postdoctoral research fellows are in training within the Health System.
A culture of innovation and discovery permeates every Icahn Mount Sinai program. Mount Sinai’s technology transfer office, one of the largest in the country, partners with faculty and trainees to pursue optimal commercialization of intellectual property to ensure that Mount Sinai discoveries and innovations translate into healthcare products and services that benefit the public.
Icahn Mount Sinai’s commitment to breakthrough science and clinical care is enhanced by academic affiliations that supplement and complement the School’s programs.
Through the Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. Additionally, MSIP develops research partnerships with industry leaders such as Merck & Co., AstraZeneca, Novo Nordisk, and others.
The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem, and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinai’s location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus, to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally.
Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Beth Israel; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.
“The movement toward evidence-based plastic surgery doesn’t have a concrete end,” explains meeting chairman, Dr. Rohrich. “This is truly a change in the way we practice our profession – a change that sets the stage for continual advances and improvements, always with an awareness of our perpetual duty to assure the safety and satisfaction of our patients.”
The annual meeting, which is open to board certified plastic surgeons, facial plastic surgeons, otolaryngologists, oculoplastic surgeons, dermatologists, residents, aestheticians and other non-physician providers, will focus on advances in topics such as aesthetic devices, advanced injection techniques, innovations in breast augmentation, and detailed analysis of facelift surgery and advanced facial anatomy. The meeting will also highlight advances in cosmetic surgery including body contouring, neuromodulators, fat grafting, breast augmentation, buttock augmentation, and liposuction.
This meeting also features a unique element, the cosmetic cadaver lab, which allows attendees hands on participation and direct observation of experts performing live demonstrations. This portion will be open to plastic surgeons, otolaryngologists, oculoplastic surgeons, and residents studying those medical specialties.
“The Dallas Cosmetic Surgery and Medicine Meeting offers unprecedented opportunities for surgeons to enhance their skills and understanding of cosmetic surgery and cosmetic medicine, “says Dr. Rohrich.
Dr. Rod J. Rohrich is a board certified plastic surgeon in Dallas, Texas. He was named the top plastic surgeon in America by Newsweek in both rhinoplasty and facelift surgery in 2021, 2022 and 2023. Dr. Rohrich is a Clinical Professor of Plastic Surgery at Baylor College of Medicine. He was the first Chair of the Department of Plastic Surgery as well as the first plastic surgeon selected as a Distinguished Teaching Professor at UT Southwestern Medical Center. He graduated from Baylor College of Medicine with high honors and completed his plastic surgery training at the University of Michigan Medical Center and fellowships at Massachusetts General Hospital/Harvard (hand/microsurgery) and Oxford University (pediatric plastic surgery). He is Chair of the Dallas Rhinoplasty Meeting, Founding Chair of the Dallas Cosmetic Surgery and Medicine Meeting, Founding Member of the Alliance in Reconstructive Surgery, and a Founding Partner of the Dallas Plastic Surgery Institute.
He is the immediate past (after serving for 18 years) Editor-in-Chief of the most respected global peer reviewed plastic surgery journal – the Plastic and Reconstructive Surgery Journal. He is Founding Editor-in-Chief/Editor Emeritus of the first open access peer reviewed plastic surgery journal, PRS Global Open. Dr. Rohrich has published over 1000 peer reviewed articles and seven textbooks in plastic surgery including a best-selling medical book entitled The Facial Danger Zones. Dr. Rohrich recently published an innovative cosmetic surgery video atlas, Cosmetic Surgery by the Masters.
Dr. Rohrich also served as president of the American Society of Plastic Surgeons (ASPS), the largest organization of board certified plastic surgeons in the world. He repeatedly has been selected by his peers as one of America’s best doctors. He received the ASPS Special Achievement Award and on three occasions has received one of his profession’s highest honors, the Plastic Surgery Foundation (PSF) Distinguished Service Award, which recognizes his contributions to education in plastic surgery. In addition, he has also been recognized by the PSF with the Plastic Surgery Foundation Distinguished Career Researcher Award for his contributions to plastic surgery research and innovations. He is also the recipient of the ASPS 2022 Honorary Citation.
Dr. Rivkin is a facial aesthetic specialist and an assistant clinical professor at the David Geffen / UCLA School of Medicine. He received his undergraduate degree from Columbia University, medical degree from the Yale University School of Medicine and completed his residency in Otolaryngology/ Head and Neck Surgery at the University of California San Diego School of Medicine. Dr. Rivkin divides his time between patient care, clinical research, physician education, media appearances and lecturing throughout the world. At his practice, RIVKIN Aesthetics, Dr. Alexander Rivkin has focused on developing and perfecting non-invasive, non-ablative cosmetic treatments. He provides expertise in creating undetectable subtle facial transformations and is a true expert in the world of aesthetic surgery with excellent credentials and a superior level of training. RIVKIN Aesthetics is located at 11645 Wilshire Blvd., Suite 800 in Los Angeles, CA. For more information, please visit http://www.westsideaesthetics.com or call 310-443-5273.
